What kind of imbecile sells at a loss when biz is booming?I swear some of these morons must be allergic to money!
Great quarterly report - expanding partnerships - first to market, breakthrough medical technology - expanded Covid testing - rosy short and long-term outlooks...
This stock should be well over a dollar by now, and inching up on its price target of $1.25.
To sell is to lose your stake.
Buh-bye, losers.